T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGTC
2051
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.06M | ﹤0.01% |
272,155
-2,446
| -0.9% | -$10.1K |
|
2052
Myriad Genetics
MYGN
$303M
| $1.06M | ﹤0.01% |
34,721
+4,964
| +17% | +$143K |
|
2053
TriNet
TNET
$3.22B
| $1.06M | ﹤0.01% |
14,654
-1,338
| -8% | -$104K |
|
|
LAZR
2054
DELISTED
Luminar Technologies
LAZR
| $1.06M | ﹤0.01% |
3,220
+513
| +19% | +$169K |
|
2055
Sprout Social
SPT
$604M
| $1.06M | ﹤0.01% |
11,858
-42,561
| -78% | -$2.95M |
|
2056
AeroVironment
AVAV
$9.59B
| $1.05M | ﹤0.01% |
10,470
-488
| -4% | -$53.7K |
|
|
SRG
2057
Seritage Growth Properties
SRG
$128M
| $1.04M | ﹤0.01% |
56,770
+1,832
| +3% | +$32.5K |
|
|
VGR
2058
DELISTED
Vector Group Ltd.
VGR
| $1.04M | ﹤0.01% |
104,207
-64,990
| -38% | -$647K |
|
2059
Adtran
ADTN
$658M
| $1.04M | ﹤0.01% |
50,345
-7,174
| -12% | -$139K |
|
2060
RLI Corp
RLI
$5.87B
| $1.04M | ﹤0.01% |
19,820
+1,472
| +8% | +$80K |
|
|
RPAI
2061
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $1.03M | ﹤0.01% |
90,254
-1,521
| -2% | -$17.8K |
|
|
ROIC
2062
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.02M | ﹤0.01% |
57,720
-6,557
| -10% | -$115K |
|
|
HT
2063
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.01M | ﹤0.01% |
94,323
-29,362
| -24% | -$324K |
|
|
SI
2064
DELISTED
Silvergate Capital Corporation
SI
| $1.01M | ﹤0.01% |
8,953
+834
| +10% | +$94.5K |
|
2065
Hyatt Hotels
H
$16.9B
| $1.01M | ﹤0.01% |
13,064
-2,300
| -15% | -$186K |
|
2066
Dave & Buster's
PLAY
$370M
| $1M | ﹤0.01% |
24,762
-1,719
| -6% | -$74.4K |
|
2067
RE/MAX Holdings
RMAX
$265M
| $989K | ﹤0.01% |
29,660
+3,340
| +13% | +$120K |
|
2068
Associated Banc-Corp
ASB
$6.07B
| $988K | ﹤0.01% |
48,253
-6,036
| -11% | -$133K |
|
2069
Vericel Corp
VCEL
$2.28B
| $983K | ﹤0.01% |
18,725
+758
| +4% | +$43.2K |
|
2070
Healthcare Services Group
HCSG
$1.45B
| $980K | ﹤0.01% |
31,031
-99
| -0.3% | -$3.01K |
|
|
SGMO
2071
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $980K | ﹤0.01% |
81,832
-7,549
| -8% | -$85.5K |
|
2072
Nu Skin
NUS
$236M
| $978K | ﹤0.01% |
17,271
+277
| +2% | +$15.8K |
|
|
VIA
2073
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $978K | ﹤0.01% |
17,270
-1,521
| -8% | -$81.2K |
|
|
FSR
2074
DELISTED
Fisker Inc.
FSR
| $971K | ﹤0.01% |
50,352
+15,652
| +45% | +$231K |
|
2075
Trustmark
TRMK
$2.8B
| $968K | ﹤0.01% |
31,433
+1,197
| +4% | +$39.5K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.